ND
Neil D. Kane
Chief Executive Officer at Glucosentient,
View Neil's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Chief Executive Officer
Present
Company Details
2-10 Employees
The Blood Glucose Meter (BGM) is a widely available and proven medical device that is used by millions of diabetics around the globe. Today’s glucose meter is the culmination of over 30 years of engineering and development efforts to make it do one thing extraordinarily well: measure blood glucose levels anytime, anywhere. At GlucoSentient, we have developed a powerful technology that is transforming the BGM into a device that is capable of quantitatively and conveniently detecting other non-glucose targets. This is made possible by our patent pending technology that translates the amount of non-glucose target to glucose. The amount of glucose is then measured by the BGM. The technology is robust and widely applicable, including heavy metal ions (environmental monitoring), small molecules (drug monitoring, drugs-of-abuse tests), protein markers (immunoassay diagnostics) and nucleic acid (molecular diagnostics) quantification.
Year Founded
2011
Social Media
Linkedin
Industry
Biotechnology
HQ Location
60 Hazelwood Drive Suite 230F Champaign, IL 61820, US
Keywords
Medical DiagnosticsPoint-of-care testsImmunoassay
Discover More About Cleveland Clinic
Contact Details
  • Email AddressN**@glucosentient.com
    Reveal Email
  • Phone Number(xxx)xxx-xxxx
    Reveal Phone

Find verified contacts of Neil D. Kane in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.